Back to search

Article

Grading HER2 at the nanoscale in clinical tissue

2026-01-14

Abstract excerpt

To guide diagnosis and treatment, breast cancer biopsies are assessed for HER2 status and assigned one of four grades (0-3+). While current practices are sufficient for detection of HER2 overexpression (3+), there is a need for more sensitive methods capable of characterising lower HER2 expression in patients who may still benefit from HER2-targeted therapies. Super-resolution fluorescence microscopy techniques, s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
705acb92-7071-5429-b7d4-532b04d0bc48
DOI
10.64898/2026.01.14.695095
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Grading HER2 at the nanoscale in clinical tissueDOI 10.64898/2026.01.14.695095
Select a neighboring publication to make it the new centre.